be certain - don't gamble
CAST® elisa
Allergy Mediator Release - It is the release of mediators of an allergic reaction, and not merely the presence of specific serum IgE, that is responsible for the clinical manifestation of an allergy.
CAST® assays: available in combination with >150 standardized and validated allergens.

CAST® ELISA the Cellular Antigen Stimulation Test, can also be considered as an in vitro allergy provocation test. The collected patient's leukocyte blood fraction will be exposed in vitro to the suspected specific allergen. After incucation the cellular supernatant will be tested for the de novo synthesis of sulfidoleukotrienes by a highly specific ELISA.
Not only enables this test the detection of IgE-mediated allergies, but also the pseudo-allergies. This latter kind of allergy is best known for Aspirin (ASA) and other non steroidal anti-inflammatory drugs (NSAIDs) and various other drugs or food additives.
Product Information
| CAST® elisa | |
|---|---|
Method |
ELISA |
Time to results |
5.5 h |
Sample Type |
200 µl whole EDTA blood |
Standard Range |
50-3200 pg/ml |
Sensitivity |
19 pg/ml |
Order Code |
EK-CAST (192 wells) EK-CAST5 (480 wells) |
| CE | |
| DOWNLOADS | ||||
|---|---|---|---|---|
Instruction
|
Technical Information |
Equine Application |
Technical Information
|
|
English |
[PDF0.3MB] | [PDF 0.3MB] | [PDF0.3MB] | [PDF 0.3MB] |
Deutsch |
[PDF 0.3MB] | |||
Francais |
* Multilingual document [EN, DE, FR, IT, ES]
Main applications for the CAST® ELISA
The CAST® assays can be used for the confirmation of any IgE mediated allergy with controversial results from classical testing (anamnese, skin testing, spec. IgE). Further information about specific fields of allergy ask for independent testing on Cellular Allergy for human and equine application.
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
Your local distributor
Order
About us
Job opportunities
Search
News
NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND
BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb more
New Seegene DPO Movie showing how this unique and proprietary technology is working to allow innovative multiplexing.
The unique and proprietary DPO™(Dual-Priming-Oligonucleotide) technology is the corner stone for all of the Seegene products, and it is the key to achieve more
New EntroGen BRAF test (V600E/K/D) for the detection of important mutations found in melanoma on your real-time PCR instrument.
EntroGen has a new BRAF test that detects, beside the V600E mutation, also the V600K and the V600D, which are important mutations found in melanoma. more
BÜHLMANN innovations and news at the JIB
At the JIB Congress in Paris, 8th – 10th November 2011, BÜHLMANN presents the MDx products of EntroGen and AutoGenomics as well as new developments of its more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | Customer Relations | About Us |
Contact |
